These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7849493)

  • 21. In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.
    Lainé S; Scarborough RJ; Lévesque D; Didierlaurent L; Soye KJ; Mougel M; Perreault JP; Gatignol A
    RNA Biol; 2011; 8(2):343-53. PubMed ID: 21422817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1.
    Yu M; Poeschla E; Yamada O; Degrandis P; Leavitt MC; Heusch M; Yees JK; Wong-Staal F; Hampel A
    Virology; 1995 Jan; 206(1):381-6. PubMed ID: 7831794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.
    Pachuk CJ; Yoon K; Moelling K; Coney LR
    Nucleic Acids Res; 1994 Feb; 22(3):301-7. PubMed ID: 8127665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.
    Bertrand E; Castanotto D; Zhou C; Carbonnelle C; Lee NS; Good P; Chatterjee S; Grange T; Pictet R; Kohn D; Engelke D; Rossi JJ
    RNA; 1997 Jan; 3(1):75-88. PubMed ID: 8990401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.
    Heidenreich O; Eckstein F
    J Biol Chem; 1992 Jan; 267(3):1904-9. PubMed ID: 1730726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells.
    Yamada O; Kraus G; Leavitt MC; Yu M; Wong-Staal F
    Virology; 1994 Nov; 205(1):121-6. PubMed ID: 7975207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.
    Bergeron LJ; Ouellet J; Perreault JP
    Curr Med Chem; 2003 Dec; 10(23):2589-97. PubMed ID: 14529473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
    Ramezani A; Ding SF; Joshi S
    Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservation of a hairpin ribozyme sequence in HIV-1 is required for efficient viral replication.
    Yamada O; Kraus G; Sargueil B; Yu Q; Burke JM; Wong-Staal F
    Virology; 1996 Jun; 220(2):361-6. PubMed ID: 8661387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antisense sequence of the HIV-1 TAR stem-loop structure covalently linked to the hairpin ribozyme enhances its catalytic activity against two artificial substrates.
    Pérez-Ruiz M; Sievers D; García-López PA; Berzal-Herranz A
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):33-42. PubMed ID: 10192287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.
    Koseki S; Tanabe T; Tani K; Asano S; Shioda T; Nagai Y; Shimada T; Ohkawa J; Taira K
    J Virol; 1999 Mar; 73(3):1868-77. PubMed ID: 9971765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1.
    Ramezani A; Ma XZ; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a29-36. PubMed ID: 11815297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme.
    Weerasinghe M; Liem SE; Asad S; Read SE; Joshi S
    J Virol; 1991 Oct; 65(10):5531-4. PubMed ID: 1895402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic properties of hairpin ribozymes derived from Chicory yellow mottle virus and arabis mosaic virus satellite RNAs.
    DeYoung M; Siwkowski AM; Lian Y; Hampel A
    Biochemistry; 1995 Dec; 34(48):15785-91. PubMed ID: 7495810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots.
    Chadalavada DM; Senchak SE; Bevilacqua PC
    J Mol Biol; 2002 Apr; 317(4):559-75. PubMed ID: 11955009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
    Xing Z; Mahadeviah S; Whitton JL
    Antisense Res Dev; 1995; 5(3):203-12. PubMed ID: 8785476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.